Clinical Trials Directory

Trials / Unknown

UnknownNCT04027595

Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists

Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy: Efficacy and Outcomes Performed by Optometrists

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Northeastern State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to formally assess the efficacy and outcomes of optometrist-performed neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy procedures.

Detailed description

Participants will undergo a pre-procedure examination to establish baseline findings and to determine if they meet the inclusion criteria. Participants will undergo the Nd: YAG laser capsulotomy procedure and will be examined at 1 hour, 1 day (if necessary), 1 week, 1 month, and 3 months following the procedure. Follow-up examinations will evaluate visual acuity improvement and possible post-procedure complications. The complication rate following the laser capsulotomy procedure is typically minimal.

Conditions

Interventions

TypeNameDescription
PROCEDURENeodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser CapsulotomyA Nd: YAG laser will be used to open the cloudy posterior capsule of the lens to improve central visual acuity.

Timeline

Start date
2019-09-17
Primary completion
2022-05-22
Completion
2022-09-30
First posted
2019-07-22
Last updated
2022-09-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04027595. Inclusion in this directory is not an endorsement.

Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists (NCT04027595) · Clinical Trials Directory